Mr. Speaker, on October 25, the Minister of Industry said that his government had an action plan to help the innovative pharmaceutical industry. The government has done nothing since then to grant the right to appeal, allowing innovative companies to stand up to their competition so that they can continue investing in research and development. Yet innovation drives the pharmaceutical industry.
When will the Minister of Industry introduce a regulation on the right to appeal in order to correct this glaring injustice in the Patent Act?